James Good
opthamology
Chemical Computing Group
Greece
Biography
Dr Good is the local lead clinician on several clinical trials investigating both immunotherapy and novel radiation techniques. He has a particular interest in novel drug/radiotherapy combinations; Dr Good sits on the trial management group of the phase 3 CompARE trial, investigating immunotherapy in combination with radiotherapy, and is deputy chief investigator of the WISTERIA trial, which investigates a DNA damage response modulator with radiotherapy.
Research Interest
Dr Good is the local lead clinician on several clinical trials investigating both immunotherapy and novel radiation techniques. He has a particular interest in novel drug/radiotherapy combinations; Dr Good sits on the trial management group of the phase 3 CompARE trial, investigating immunotherapy in combination with radiotherapy, and is deputy chief investigator of the WISTERIA trial, which investigates a DNA damage response modulator with radiotherapy.
